Mechanisms of disease: Single-Gene mutations resulting in reproductive dysfunction in women

New England Journal of Medicine

Volumn 340, Issue 9, 1999, Pages 709-718

  Adashi, Eli Y ^a   Hennebold, Jon D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; FEMALE INFERTILITY; GENE MUTATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LUTEINIZING HORMONE RELEASE; PRIORITY JOURNAL; REVIEW; ALBRIGHT SYNDROME; CONGENITAL ADRENAL HYPERPLASIA; GALACTOSEMIA; GENETICS; GONADAL DISEASE; MUTATION;

AROMATASE;

ADRENAL HYPERPLASIA, CONGENITAL; AROMATASE; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; GALACTOSEMIAS; GONADAL DISORDERS; HUMANS; INFERTILITY, FEMALE; MUTATION;

EID: 0033522002     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199903043400907     Document Type: Review

References (75)

1. Hotchkiss J, Knobil E. The hypothalamic pulse generator: the reproductive core. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven, 1996:123-62.
2. Evans WS, Griffin ML, Yankov VI. The pituitary gonadotroph: dynamics of gonadotropin release. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven, 1996:181-210.
3. Adashi EY. The ovarian follicle: life cycle of a pelvic clock. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven, 1996:211-34.
4. Newfield RS, New MI. 21-Hydroxylase deficiency. Ann N Y Acad Sci 1997;816:219-29.
5. Rosler A, White PC. Mutations in human 11β-hydroxylase genes: 110-hydroxylase deficiency in Jews of Morocco and corticosterone methyl-oxidase II deficiency in Jews of Iran. J Steroid Biochem Mol Biol 1993;45: 99-106.
6. New MI, Newfield RS. Congenital adrenal hyperplasia. Curr Ther Endocrinol Metab 1997;6:179-87.
7. Pang S. Congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 1997;26:853-91.
8. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993;365:652-4.
9. Kremer H, Mariman E, Otten BJ, et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet 1993;2:1779-83.
10. Kosugi S, Van Dop C, Geffner ME, et al. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet 1995; 4:183-8.
11. Latronico AC, Anasti J, Arnhold IJ, et al. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1995;80:2490-4.
12. Laue L, Chan WY, Hsueh AJ, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci U S A 1995;92:1906-10.
13. Andersson S, Geissler WM, Wu L, et al. Molecular genetics and pathophysiology of 170-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996;81:130-6.
14. Rosler A, Silverstein S, Abeliovich D. A (R80Q) mutation in 17β-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996;81:1827-31.
15. Zhang Y, Word RA, Fesmire S, Carr BR, Rainey WE. Human ovarian expression of 17β-hydroxysteroid dehydrogenase types 1, 2, and 3. J Clin Endocrinol Metab 1996;81:3594-8.
16. Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM, Huhtaniemi IT. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. Fertil Steril 1997;67: 998-1004.
17. Bick D, Franco B, Sherins RJ, et al. Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med 1992;326:1752-5.
18. Bouloux PM, Munroe P, Kirk J, Besser GM. Sex and smell - an enigma resolved. J Endocrinol 1992;133:323-6.
19. Guioli S, Incerti B, Zanaria E, et al. Kallmann syndrome due to a translocation resulting in an X/Y fusion gene. Nat Genet 1992;1:337-40.
20. Hardelin JP, Levilliers J, Young J, et al. Xp22.3 deletions in isolated familial Kallmann's syndrome. J Clin Endocrinol Metab 1993;76:827-31.
21. Petit C. Molecular basis of the X-chromosome linked Kallmann's syndrome. Trends Endocrinol Metab 1993;4:8-13.
22. Quinton R, Duke VM, de Zoysa PA, et al. The neurobiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab 1996;81:3010-7.
23. Schwanzel-Fukuda M, Pfaff DW. Origin of luteinizing hormone-releasing hormone neurons. Nature 1989;338:161-4.
24. Waldstreicher J, Seminara SB, Jameson JL, et al. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 1996;81:4388-95.
25. Franco B, Guioli S, Pragliola A, et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991;353:529-36.
26. Legouis R, Hardelin JP, Levilliers J, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991;67:423-35.
27. de Roux N, Young J, Misrahi M, et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 1997;337:1597-602.
28. Rabin D, Spitz I, Bercovici B, et al. Isolated deficiency of follicle-stimulating hormone: clinical and laboratory features. N Engl J Med 1972;287: 13137.
29. Spitz IM, Diamant Y, Rosen E, et al. Isolated gonadotropin deficiency: a heterogeneous syndrome. N Engl J Med 1974;290:10-5.
30. Rabinowitz D, Benveniste R, Lindner J, Lorber D, Daniell J. Isolated follicle-stimulating hormone deficiency revisited: ovulation and conception in presence of circulating antibody to follicle-stimulating hormone. N Engl J Med 1979;300:126-8.
31. Matthews CH, Borgato S, Beck-Peccoz P, et al. Primary amcnorrhoea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone. Nat Genet 1993;5:83-6.
32. Layman LC, Lee E-J, Peak DB, et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene. N Engl J Med 1997;337:607-11.
33. Aittomaki K, Lucena JLD, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-68.
34. Aittomaki K, Herva R, Stenman UH, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab 1996;81:3722-6.
35. Kotlar TJ, Young RH, Albanese C, Crowley WF Jr, Scully RE, Jameson JL. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J Clin Endocrinol Metab 1997; 82:1020-6.
36. Toledo SPA, Brunner HG, Kraaij R, et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J Clin Endocrinol Metab 1996;81:3850-4.
37. Kremer H, Kraaij R, Toledo SPA, et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 1995;9:160-4.
38. Latronico AC, Anasti J, Arahold IJP, et al. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996;334:507-12.
39. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996;17:221-44.
40. Lin D, Sugawara T, Strauss JF III, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267:1828-31.
41. Okuyama E, Nishi N, Onishi S, et al. A novel splicing junction mutation in the gene for the steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 1997;82-2337-42.
42. Bose HS, Pescovitz OH, Miller WL. Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab 1997;82:1511-5.
43. Fujieda K, Tajima T, Nakae J, et al. Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia: ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest 1997;99:1265-71.
44. Nakae J, Tajima T, Sugawara T, et al. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet 1997;6:571-6.
45. Bose HS, Sugawara T, Strauss JF III, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 1996; 335:1870-8.
46. Isselbacher KJ. Galactosemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The metabolic basis of inherited disease. 2nd ed. New York: McGraw-Hill, 1966:178-88.
47. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304:994-8.
48. Kaufman FR, Donnell GN, Roe TF, Kogut MD. Gonadal function in patients with galactosaemia. J Inherit Metab Dis 1986;9:140-6.
49. McKusick VA. Mendelian inheritance in man: catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes. 10th ed. Baltimore: Johns Hopkins University Press, 1992.
50. Levy HL, Driscoll SG, Porensky RS, Wender DF. Ovarian failure in galactosemia. N Engl J Med 1984;310:50.
51. Kaufman FR, Xu YK, Ng WG, Silva PD, Lobo RA, Donnell GN. Gonadal function and ovarian galactose metabolism in classic galactosemia. Acta Endocrinol (Copenh) 1989;120:129-33.
52. Comite F, Shawker TH, Pescovitz OH, Loriaux DL, Cutler GB Jr. Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome. N Engl J Med 1984;311:1032-6.
53. Feuillan PP, Jones J, Oerter KE, Manasco PK, Cutler GB Jr. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome. J Clin Endocrinol Metab 1991;73: 1370-3.
54. Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet 1986;29:321-4.
55. Lemli L. Fibrous dysplasia of bone: report of female monozygotic twins with and without the McCune-Albright syndrome. J Pediatr 1977; 91:947-9.
56. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688-95.
57. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 1992;89:5152-6.
58. Spiegel AM. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996;81:2434-42.
59. Lyons J, Landis CA, Harsh G, et al. Two G protein oncogenes in human endocrine tumors. Science 1990;249:655-9.
60. Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991;72:560-6.
61. Harada N, Ogawa H, Shozu M, Yamada K. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am J Hum Genet 1992;51:666-72.
62. Harada N, Ogawa H, Shozu M, et al. Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency. J Biol Chem 1992;267:4781-5
63. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994;78:1287-92.
64. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80: 3689-98.
65. Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 1997;82:1739-45.
66. Bulun SE. Aromatase deficiency in women and men: would you have predicted the phenotypes? J Clin Endocrinol Metab 1996;81:867-71.
67. New MI. Congenital virilizing adrenal hyperplasia. In: Adashi EY, Rock JA, Rosenwaks Z, eds. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven, 1996:1555-69.
68. Bongiovinni AM, Kellenbenz G. The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase. J Clin Invest 1962;41: 2086-92.
69. Sanchez R, Rheaume E, Laflamme N, Rosenfield RL, Labrie F, Simard J. Detection and functional characterization of the novel missense mutation Y254D in type II 3β-hydroxysteroid dehydrogenase (3β HSD) gene of a female patient with nonsalt-losing 3β HSD deficiency. J Clin Endocrinol Metab 1994;78:561-7.
70. Rheaume E, Lachance Y, Zhao HF, et al. Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol Endocrinol 1991;5:1147-57.
71. Zhao HF, Labrie C, Simard J, et al. Characterization of rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase cDNAs and differential tissue-specific expression of the corresponding mRNAs in steroidogenic and peripheral tissues. J Biol Chem 1991;266:583-93.
72. Penning TM. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev 1997;18:281-305.
73. Zerah M, Rheaume E, Mani P, et al. No evidence of mutations in the genes for type I and type II 3β-hydroxysteroid dehydrogenase (3β HSD) in nonclassical 3β HSD deficiency. J Clin Endocrinol Metab 1994;79: 1811-7.
74. Zuber MX, Mason JI, Simpson ER, Waterman MR. Simultaneous transfection of COS-1 cells with mitochondrial and microsomal steroid hydroxylases: incorporation of a steroidogenic pathway into nonsteroidogenic cells. Proc Natl Acad Sci U S A 1988;85:699-703.
75. Mallin SR. Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency: two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries. Ann Intern Med 1969;70:69-75